2005 - maintenantNeurodegeneration department.
cell and molecular biology
Novartis Institutes for Biomedical Research USA
- Scientist
2004 - 2005Responsible for Cell Based Assay Development including reporter gene assays on the PI3K and mTOR pathways
Harvard Medical School
- Research associate
2002 - 2004@ Research Assistant in a molecular medicine and gene therapy laboratory
Set up a Gene Regulation system based on the ribozyme self cleavage property
@ Drug screening in the Whitehead Institute – MIT (Massachusetts Institute of Technology) (Cambridge - MA)
PUBLICATIONS :
@ Laising Yen, J.Svendsen, J.S. Lee, J.T. Gray, Maxime Magnier, T. Baba, R.J. D’Amato, and R.C. Mulligan. Exogenous control of mammalian gene expression via modulation of RNA self-cleavage. Nature 431 : 471-476 Sept 2004
@ Laising Yen, Maxime Magnier, Brent Stockwell, and R.C. Mulligan. Identification of hammerhead ribozyme inhibitors by cell-based high-throughput screening (RNA, in press)
Genethon
- Charge de projet
Ivry2001 - 2002@ Responsible for validation of titration methods (Murine Leukemia Virus)
@ Responsible of setting up environmental control in production zone
